Psilera, Inc. (Psilera), a leading biotechnology company developing therapies for rare neurological disorders, has received initial toxicity readouts from maximum tolerated dose (MTD) in vivo studies showing a strong safety profile.
Psilera, Inc. (Psilera), a leading biotechnology company developing therapies for rare neurological disorders, has received initial toxicity readouts from maximum tolerated dose (MTD) in vivo studies showing a strong safety profile.
Designed by doctors. Powered by AI.
Owned by you.